Egacos B Tabs.
Egacos B Tabs.
Bilastine 20 Mg Tablets PCD Franchise in India | Egacos-B Tablets
The Indian respiratory healthcare industry is witnessing an unparalleled demand owing to rising pollution and increasing seasonal allergens in urban and rural locations. This makes expanding your pharmaceutical company with a bilastine 20 mg tablets PCD franchise in India a highly profitable commercial opportunity for pharmaceutical distributors. We at SNU Biocare are the leading producers of high-quality medicines for allergies & asthma, such as Egacos-B (Bilastine 20 mg + Montelukast 10 mg), in accordance with WHO-GMP & ISO quality standards. Additionally, our advanced manufacturing facility guarantees therapeutic efficacy, batch uniformity, and high shelf stability of each production batch.
Being a part of SNU Biocare, regional business associates get a unique territorial monopoly, eliminating any brand competition. In addition, highly competitive trade prices make it easy for distributors to earn healthy profits while addressing critical medical needs of consumers. Thus, getting bilastine 20 mg tablets PCD franchise in India gives you a strong foundation for scaling up your distribution network.
Egacos-B Tablets Uses
Egacos-B Tablets contain:
Bilastine 20 mg + Montelukast 10 mg
It is used for:
- Allergic rhinitis
- Seasonal allergies
- Sneezing, runny nose & nasal congestion
- Allergy-related itching
- Asthma-related allergic symptoms
- Long-term allergy control
How Egacos-B Tablets work
Egacos-B combines an antihistamine (Bilastine) and a leukotriene receptor antagonist (Montelukast).
Together, they block allergy-causing chemicals, reduce inflammation, and provide long-lasting relief from allergic symptoms.
What Is Bilastine 20 Mg + Montelukast 10 Mg Used For?
Bilastine 20 mg + Montelukast 10 Mg helps in providing high-potency relief to patients having severe cases of seasonal and perennial allergic rhinitis. It quickly treats troublesome upper respiratory symptoms like incessant sneezing, abundant nasal discharge, postnasal drip, and itchy, watering eyes. Patients can breathe easily without facing any discomfort because of asthmatic bronchospasms, airway hyper-responsiveness, and troublesome nocturnal breathing attacks. For businesses interested in the commercial potential of this combination, explore our guide on Bilastine Montelukast PCD franchise opportunities in India.
This powerful formulation also helps in preventing chronic airway inflammation induced by environmental dust, pollen, and pollution. Often, healthcare providers prescribe this combo for treating chronic idiopathic urticaria to reduce skin hives, intense itching, and redness. Thus, the dual mechanism of action blocks the peripheral histamine H1 receptors and inhibits leukotrienes to prevent inflammation in the body. Eventually, it works like a strong and non-sedative respiratory shield that improves the quality of life of allergy sufferers.
What Are the Benefits of Bilastine Montelukast Tablets?
Dual Mechanism of Action
Bilastine acts as a highly selective H1 receptor blocker, while Montelukast works as a potent leukotriene receptor blocker. Hence, this dual mechanism of action works more effectively against complex allergic attacks as compared to single-agent antihistamines. By blocking the inflammatory pathways, it helps in quick resolution of symptoms and restoration of normal airway functioning.
Advanced Non-Sedative Patient Profile
Antihistamines from earlier generations cause central nervous system depression due to which patients often face side effects like daytime sleepiness, fatigue, and impairment of psychomotor performance. But Bilastine doesn’t cross the blood-brain barrier; hence it offers a high safety profile. Thus, patients can take their daily dosage without feeling tired to remain energized and focused throughout the entire day.
Continuous Protection to Airways
Montelukast keeps hyper-responsive respiratory tracts secure from sudden triggers like cold air, exercise, airborne allergens, and chemicals. Thus, consistent use prevents exercise-induced bronchoconstriction and reduces coughing attacks at night. Continuous protection of bronchial tissues maintains a consistent sleep pattern and respiratory comfort.
Excellent Patient Adherence
The combination of two important anti-allergic components in a single daily dosage makes treatment simpler for all kinds of patients. Thus, clinicians prefer this medication due to reduced pill burden, which leads to increased prescription frequency.
Market Commercial Potential
Escalating pollution levels and altered weather conditions in Indian cities have made advanced anti-allergic medicines a permanent need. Therefore, adding this in-demand, fast-moving product to your pharmaceutical portfolio helps you to achieve quick sales turnover, revenue growth, and financial prosperity for your regional distributors.
How Can Bilastine Montelukast Tablets Boost a PCD Portfolio?
| PORTFOLIO ADVANTAGE | COMMERCIAL BENEFIT | BUSINESS IMPACT |
|---|---|---|
| Year-Round Demand | Anti-allergic and respiratory care products witness consistently high demand among consumers in all seasons. | Ensures steady cash flow, predictable stock turnover, and repeat orders during the whole year. |
| Monopoly Operations | The franchise partners get exclusive territorial rights to market bilastine montelukast tablets PCD locally. | Prevents intra-brand competition and price wars in the territory and makes your brand dominant in the market. |
| High Profit Margins | Direct-from-factory competitive prices offer distribution margins of 45% – 75%. | Increases return on investment and quick recovery of capital. |
| Wide Acceptance by Physicians | ENT Specialists, Pulmonologists, Allergists, Pediatricians, and General Physicians prescribe this combination on a frequent basis. | This assists in quick physician switches and increased market penetration. |
| Alu-Alu Moisture Barrier | Special packaging prevents the active pharmaceutical ingredients from moisture, humidity, and heat. | Guarantees longer shelf life and no degradation of the products. |
Why Choose SNU Biocare for Bilastine 20 Mg Tablets PCD Franchise?
SNU Biocare adheres to stringent WHO-GMP and ISO certification protocols to ensure the quality and efficacy of our products. We are also able to provide territorial monopoly franchise rights of our bilastine 20 mg tablets PCD franchise in India, enabling you to have a territorial monopoly.
Further, our factory direct pricing system will enable you to maximize your profit margins and overcome regional competition. We also provide professional marketing kits, which include visual aids, physician samples, catch cards and reminder cards for franchisees. Further, our logistics management will help us to fulfill orders promptly and avoid shortages. Acquiring a bilastine 20 mg tablets PCD franchise in india with us ensures long-term growth.
Product Specifications & Packing Details
| Parameter | Product Specification Details |
|---|---|
| Brand Name | Egacos-B Tablets |
| Generic Name | Bilastine + Montelukast Tablets |
| Active Composition | Bilastine 20 mg + Montelukast 10 mg |
| Dosage Form | Tablets |
| Therapeutic Category | Anti-Allergic & Respiratory Care |
| Packing | Alu-Alu Blister Pack |
| Quality Certification | WHO-GMP & ISO Compliant Manufacturing |
| Product Availability | Ready Stock for Pan-India Distribution |
| Promotional Support | Visual Aids, MR Bags, Reminder Cards, Product Literature & Marketing Inputs |
| Business Opportunity | Monopoly-Based PCD Pharma Franchise Across India* |
*Subject to company policy and location availability.
How to Inquire for Bilastine 20 Mg Tablets PCD Franchise?
Product Catalog Request
Potential business partners can check our complete product portfolio online or request our product literature for further evaluation. Then, they should select bilastine montelukast tablets PCD and other complementary respiratory care, ENT, and general medicine products to create a complete, competitive market catalog of your region.
Verification of Territorial Monopoly Rights
Franchise partners must contact our franchise desk to confirm that the particular geographic location is unrepresented in their target area. Thus, getting an exclusive and unrepresented territory will protect their investments against internal brand competition and help in creating a dedicated physician network.
Verification of Documents
Provide copies of your active wholesale drug license along with your GST registration details for verification. Our legal team will confirm your documents and draft partnership contracts without wasting time.
Allocation of Capital and Order
Start with a product order considering market requirements through investment packages from ₹25,000 to ₹50,000. The low entry barriers make it easy for ambitious pharmaceutical individuals to begin their pharma franchise for bilastine tablets.
Execution of Agreement and Supply
Execute the agreement and get a territorial monopoly certificate along with a complete set of promotional material. Once done, our logistics team will supply commercial stock of products instantly for selling and meet healthcare professionals. Starting your Bilastine 20 mg tablets PCD franchise in India has never been easier.
Partner with SNU Biocare for Bilastine 20 Mg Tablets PCD Franchise
Expand your pharmaceutical business with Egacos-B Tablets backed by WHO-GMP and ISO-compliant manufacturing, monopoly opportunities, promotional support, and reliable nationwide distribution.
📞 Call: +91 70878 76666 |
📧 Email: snubiocare.query@gmail.com |
🌐 Website: www.snubiocare.in
FAQs (SNU Biocare)
Q 1: What minimum capital is needed to start a PCD franchise of bilastine tablets?
You can begin a pharma franchise for bilastine tablets in India with an investment cost of at least ₹25,000 & ₹50,000.
Q 2: Do you have territorial monopoly on bilastine 20 mg franchise?
Yes, we do provide a full territorial monopoly on our bilastine 20 mg franchise. This offers you exclusive distribution rights in your allocated district without any brand competition within the company.
Q3: What is the advantage of using Bilastine over old antihistamine molecules?
Choosing a bilastine 20 mg franchise offers a non-sedative molecule that does not cross the blood-brain barrier. Hence, it is highly effective in relieving allergic symptoms without causing drowsiness and cognitive impairment.
Q4: What type of marketing tools are provided by SNU Biocare for the regional franchise holders?
Our company offers full support in marketing by providing us with glossy visual tools, product glossaries, catch card samples, MR bags, and reminder notes for doctor detailing.
Q5: How does SNU Biocare ensure the stability of its bilastine tablet line?
We use the latest Alu-Alu blister foils to package our bilastine 20 mg tablets PCD franchise in India.
Copyright © 2026 Snu Biocare All Rights Reserved